First-in-Human trial tests 'Off-the-Shelf' cell therapy for Tough-to-Treat cancers
NCT ID NCT07366658
Summary
This is the first time a new cell therapy called NEUK203-13 Injection is being tested in people. The study aims to see if it is safe and can help control tumors in patients with advanced small cell lung cancer or other neuroendocrine tumors that have stopped responding to standard treatments. Up to 9 patients will receive the therapy, which involves a special type of immune cell designed to find and attack cancer cells.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROENDOCRINE TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cancer Hospital of CICAMS
Beijing, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.